Company
Muna Therapeutics
- AI
- Biotech
- Location:
- Frederiksberg, Denmark
Description
Muna Therapeutics discovers and develops small-molecule therapies that slow or stop neurodegenerative diseases by resolving neuroinflammation, normalizing microglial function, and restoring neuronal protection using protein structural methods, AI-driven computational chemistry, and cell-based screening.
Muna Therapeutics is located in the Copenhagen ecosystem.
Related
Sens-vueSens-vue provides AI-powered eye disease screening software and remote specialist consultation tools for clinicians and patients, offering…
Herantis PharmaHerantis Pharma develops disease-modifying therapies designed to stop or reverse progression of neurodegenerative diseases, applying drug…
KvantifyKvantify develops software and services that route calculations across quantum and classical architectures, accelerating molecular…
BioInvent InternationalBioInvent International discovers and develops antibody therapeutics for cancer treatment, using immunology, cancer biology, antibody…
BraineverBrainever develops hEN1 and hOTX2 homeoprotein drug candidates intended to limit neurodegenerative disease progression by preventing…
Particle AnalyticalParticle Analytical provides GMP-certified solid-state characterization services that perform solid form screening, method development and…
HAYA TherapeuticsHAYA Therapeutics develops RNA-guided medicines that use functional genomics and computational tools to identify, target, and monitor…
HealxHealx builds AI-driven drug discovery and development tools and therapies for rare disease patients, applying AI across discovery,…
WhiteLab GenomicsWhiteLab Genomics builds AI-driven computational platforms to design and optimize genomic medicines, producing in‑silico modules and…